127 related articles for article (PubMed ID: 20407410)
21. Bacteremia in narcotic addicts at the Detroit Medical Center. II. Infectious endocarditis: a prospective comparative study.
Levine DP; Crane LR; Zervos MJ
Rev Infect Dis; 1986; 8(3):374-96. PubMed ID: 3755255
[TBL] [Abstract][Full Text] [Related]
22. A novel combination regimen for the treatment of refractory bacteremia due to multidrug-resistant Pseudomonas aeruginosa in a liver transplant recipient.
Sun HY; Shields RK; Cacciarelli TV; Muder RR; Singh N
Transpl Infect Dis; 2010 Dec; 12(6):555-60. PubMed ID: 20626709
[TBL] [Abstract][Full Text] [Related]
23. The changing character of infective endocarditis.
Quinn EL; Burch KH; Cox F; Fisher E; Madhavan T
Am Fam Physician; 1975 Mar; 11(3):117-24. PubMed ID: 803764
[TBL] [Abstract][Full Text] [Related]
24. Comparison of antibiotic susceptibility patterns in Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) with invasive Pseudomonas aeruginosa from non-CF patients.
Rao P; McCaughan J; McCalmont M; Goldsmith CE; Hall V; Millar BC; McCann MA; Downey DG; Rendall JC; Elborn JS; Moore JE
J Cyst Fibros; 2012 Jul; 11(4):349-52. PubMed ID: 22325689
[No Abstract] [Full Text] [Related]
25. Endocarditis associated with Comamonas acidovorans.
Horowitz H; Gilroy S; Feinstein S; Gilardi G
J Clin Microbiol; 1990 Jan; 28(1):143-5. PubMed ID: 2298872
[TBL] [Abstract][Full Text] [Related]
26. Combination antibiotic therapy for Pseudomonas aeruginosa bacteraemia.
Paul M; Leibovici L
Lancet Infect Dis; 2005 Apr; 5(4):192-3; discussion 193-4. PubMed ID: 15792730
[No Abstract] [Full Text] [Related]
27. A propensity score-matched analysis of the impact of minimum inhibitory concentration on mortality in patients with Pseudomonas aeruginosa bacteremia treated with cefepime or ceftazidime.
Ratliff AR; Gentry CA; Williams RJ
Diagn Microbiol Infect Dis; 2017 Apr; 87(4):376-381. PubMed ID: 28087171
[TBL] [Abstract][Full Text] [Related]
28. Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
Lee CH; Su TY; Ye JJ; Hsu PC; Kuo AJ; Chia JH; Lee MH
J Microbiol Immunol Infect; 2017 Oct; 50(5):677-683. PubMed ID: 26188977
[TBL] [Abstract][Full Text] [Related]
29. [A case of Pseudomonas mendocina endocarditis].
Suel P; Martin P; Berthelot G; Robaday S; Etienne M; Chibani A
Med Mal Infect; 2011 Feb; 41(2):109-10. PubMed ID: 21094007
[No Abstract] [Full Text] [Related]
30. Analysis of prognostic factors in 274 consecutive episodes of Pseudomonas aeruginosa bacteremia.
Mallolas J; Gatell JM; Miró JM; Marco F; Bisbe J; Jiménez de Anta MT; Soriano E
Antibiot Chemother (1971); 1991; 44():106-14. PubMed ID: 1801628
[No Abstract] [Full Text] [Related]
31. Non-nosocomial healthcare-associated left-sided Pseudomonas aeruginosa endocarditis: a case report and literature review.
Hagiya H; Tanaka T; Takimoto K; Yoshida H; Yamamoto N; Akeda Y; Tomono K
BMC Infect Dis; 2016 Aug; 16(1):431. PubMed ID: 27543116
[TBL] [Abstract][Full Text] [Related]
32. Treatment of pseudomonal endocarditis with high-dose aminoglycosides.
Rybak MJ; Boike SC; Bush PW
Drug Intell Clin Pharm; 1982 Sep; 16(9):700-2. PubMed ID: 6813092
[No Abstract] [Full Text] [Related]
33. Pseudomonas aeruginosa bloodstream infections: how should we treat them?
van Delden C
Int J Antimicrob Agents; 2007 Nov; 30 Suppl 1():S71-5. PubMed ID: 17698326
[TBL] [Abstract][Full Text] [Related]
34. Pseudomonas aeruginosa endocarditis. A report of nine cases.
Witchitz S; Gibert C; Witchitz J; Gougerot M; Vachon F; Vic-Dupont V
Eur J Cardiol; 1976 Mar; 4(1):91-7. PubMed ID: 816657
[TBL] [Abstract][Full Text] [Related]
35. A successfully treated case of Pseudomonas endocarditis, with review of the literature.
Uthman SM; Uwayda MM
J Med Liban; 1967; 20(4):245-52. PubMed ID: 4297503
[No Abstract] [Full Text] [Related]
36. Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin-tazobactam: implications on the appropriateness of the resistance breakpoint.
Tam VH; Gamez EA; Weston JS; Gerard LN; Larocco MT; Caeiro JP; Gentry LO; Garey KW
Clin Infect Dis; 2008 Mar; 46(6):862-7. PubMed ID: 18279040
[TBL] [Abstract][Full Text] [Related]
37. Ceftolozane/Tazobactam Therapy of Respiratory Infections due to Multidrug-Resistant Pseudomonas aeruginosa.
Gelfand MS; Cleveland KO
Clin Infect Dis; 2015 Sep; 61(5):853-5. PubMed ID: 26021991
[No Abstract] [Full Text] [Related]
38. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
Dambrauskiene A; Adukauskiene D; Jeroch J; Vitkauskiene A
Medicina (Kaunas); 2009; 45(1):1-7. PubMed ID: 19223699
[TBL] [Abstract][Full Text] [Related]
39. Prosthetic valve endocarditis caused by metallo-beta-lactamase-producing Pseudomonas aeruginosa.
Kato Y; Ohashi H; Tsutsumi Y; Murakami T; Takahashi Y
J Card Surg; 2009; 24(3):347-9. PubMed ID: 19438796
[TBL] [Abstract][Full Text] [Related]
40. Optimization of dose and dose regimen of biapenem based on pharmacokinetic and pharmacodynamic analysis.
Miyazaki S
J Infect Chemother; 2004 Apr; 10(2):135. PubMed ID: 15160313
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
